You searched for "vitreoretinal"
Simulated ocular surgery – strabismus surgery
See also Simulated ocular surgery and Simulated ocular surgery: pars plane vitrectomy and scleral buckling surgery Strabismus surgery requires a range of skills, distinct to those required for intraocular surgery. Even if a trainee does not plan to become a...
Anatomical and functional outcomes following switching from aflibercept to ranibizumab in NARMD
5 June 2020
| Jonathan Chan
|
EYE - Vitreo-Retinal
This is a six-month, prospective, single-arm study in the UK and Germany. A total of 100 patients were enrolled (one in the primary failure group, 99 in the suboptimal treatment response group), treated three-monthly intravitreal ranibizumab injections (0.5mg), and then...
Development of eyecare services in Dominica: Past, present, and future
3 October 2024
| Hazel Shillingford-Ricketts, Kevin Melanson, Marcia Zondervan, Covadonga Bascaran
|
EYE - General
Dominica is a small island developing state in the Caribbean with a population of approximately 73,000 people [1] and has a long and proud history of developing eyecare services through international partnerships. This article will give you an outline of...
Psychiatric Consequences of Ophthalmic Disease
1 December 2013
| Amjad Akram, Masood Alam Shah
In part two of this series on ophthalmology and psychiatry, the authors will cover the possible psychiatric consequences of ophthalmic disease. The following conditions will be discussed: a. Black patch psychosis b. Psychological state in blindness c. Phobias in the...
Ophthalmic learning through the lens of cognitivism and constructivism
9 October 2020
| Rasan Burhan, Andrew Ross, Sajeel Ahmed
|
EYE - General
Learning in ophthalmology is multi-faceted, from understanding the fundamentals of eye anatomy and physiology to higher order skills such as performing cataract and vitreoretinal surgery. Having a strong foundation in the basics is a necessity for higher order knowledge synthesis,...
The effect of everolimus on retinal pigment epithelium and proliferative vitreo-retinopathy
1 August 2018
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
The principal cells involved in proliferative vitreo-retinopathy (PVR) are retinal pigment epithelial cells (RPE). Everolimus is a drug used in renal cell carcinoma which targets and inhibits a key regulatory protein in cancer (mTOR). In this study, the authors investigated...
Correlation between anti-retinal antibodies and proliferative vitreoretinopathy (PVR)
1 October 2018
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
The pathological basis of PVR is not clearly understood and there are no effective medications targeting this condition. This cross-sectional study looked at the possible association of anti-retinal antibodies with patients with PVR and retinal detachment (RD). Aqueous and vitreous...
Infliximab in treatment of PVR
28 February 2025
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
In this phase 2 randomly controlled trial, 66 patients with primary rhegmatogenous retinal detachment and grade C proliferative vitreoretinopathy (PVR) were randomised in a 1:1 ratio to undergo pars plana vitrectomy (PPV) and silicone oil (SO) injection with or without...
Quiz Feb/Mar 2024
2 February 2024
| Christopher Bell
|
EYE - Oncology, EYE - Pathology, EYE - Paediatrics, EYE - Strabismus, EYE - General
History A 21-month-old boy presented to his local ophthalmology department with a left proptotic eye from a growing cystic lesion known to be present from birth. Notes taken on presentation were: Known left microphthalmia with chorio-retinal coloboma, contralateral eye was...
Belfast briefing: Retina Day roundup from the RCOphth 2024 Annual Congress
2 August 2024
| Rod McNeil
|
EYE - General
Belfast hosted this year’s Royal College of Ophthalmologists’ (RCOphth) Annual Congress, a meeting dedicated to sharing advances, knowledge and clinical practice points in ophthalmic care. This article summarises selected talks by medical and surgical retina specialists during the Retina Subspecialty...
Intravitreal Ziv-Aflibercept: safety analysis
7 December 2020
| Su Young
|
EYE - Vitreo-Retinal
Ziv-Aflibercept (Zaltrap; Sanofi-Aventis U.S LLS, Bridgewater, NJ) was originally introduced as an intravenous formulation for metastatic colorectal cancer. The adoption of Ziv-Aflibercept in ophthalmic practice was similar to bevacizumab, and reports have previously examined one to two year visual outcomes...
